Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cirsium oligophyllum extract is a botanical preparation derived from the aerial and/or whole parts of the thistle species *Cirsium oligophyllum*, native to East Asia and used traditionally in Chinese, Japanese, and Korean medicine. The extract contains bioactive compounds such as flavonoids, saponins, and polyphenols, and has been described in traditional uses for supporting blood circulation, reducing inflammation, promoting liver health, treating bleeding disorders, and wound healing[3][1]. Scientific studies have suggested that the extract promotes lipolysis (fat breakdown) via β adrenergic receptor activation and upregulation of uncoupling proteins (notably UCP1 and UCP3), contributing to reduced body fat and potential utility in managing obesity. These effects have been demonstrated primarily in animal models, with no robust clinical trials in humans to date[2][4][5]. Other proposed activities include antioxidant, anti-inflammatory, antimicrobial, and potential agricultural benefits.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cirsium oligophyllum extract.